Dissolution Methods

Dissolution Methods Database Disclaimer

The Dissolution Methods Database has been prepared by the Division of Bioequivalence, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration. The dissolution methods contained in the database are recommended methods that are not binding on FDA or others. We will consider alternate methods when supported by appropriate data. We recognize that the database contains a large amount of material, and methods and specifications may change over time. We welcome comments or suggested changes to the database. We plan to revise the web site on an ongoing basis.

Please send suggested changes to this database, along with supporting documentation to:

Division of Biopharmaceutics (HFD-003)
Office of New Drug Products
Office of Pharmaceutical Quality
10903 New Hampshire Ave
Silver Spring, MD 20993

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English